Delivery Order SPE2DR25D3005-SPE2DR26FP8UK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,962.71 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count) on January 6, 2026, with a contract ceiling value of $5,823.04 and an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and running through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,619.93 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.20 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,521.98 delivery order on December 4, 2025, for the supply of Isotretinoin 40 mg capsules (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 5, 2025, and performance to be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (30-count units) valued at $1,153.95, with a firm fixed price structure and ultimate completion date of September 23, 2025. This competitively awarded, non-set-aside contract represents a continuation order under AmerisourceBergen's existing pharmaceutical supply agreements with DLA. The work will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $6,969.33 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) with a firm fixed price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by April 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and deliver this pharmaceutical product to...
- The Defense Logistics Agency awarded a delivery order valued at $5,713.26 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Isotretinoin is a potent retinoid medication primarily used for severe acne...
- The Defense Logistics Agency awarded a delivery order valued at $1,596.00 to Amerisourcebergen Drug Corp for the supply of Isotretinoin 30 mg capsules (10-count units) on January 8, 2026, with an ultimate completion date of January 9, 2026. This competitively awarded, firm fixed-price delivery order is being performed at the awardee's facility in Conshohocken, Pennsylvania, and carries no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8UKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,283.59 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packages) on January 21, 2026, with completion targeted for January 22, 2026. This firm fixed-price, non-set-aside contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The current order for Isotretinoin, a prescription medication used in dermatological treatment, represents a routine task order fulfillment under this established contract vehicle supporting Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/20/26 |